“First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results” (2018) Swiss Medical Weekly, 148(0708), p. w14593. doi:10.4414/smw.2018.14593.